Tüdőrák: vizsgálatok itt: Kína
1144 trials · From ClinicalTrials.gov, checked 2026. november 16.. Ask the study team whether a trial fits you.
- No phaseTaking peopleTransthoracic vs Transbronchial Radiofrequency Ablation for Lung Cancer
- Where
- Shanghai
- Életkor
- 18 év and over
- People
- 110
- Run by
- Shanghai Chest Hospital
See details and how to joinNCT06503744 - 3. fázisTaking peopleA Phase III Study Comparing Taletrectinib With Standard Therapy in ROS1 Positive Locally Advanced or Metastatic Non-small Cell Lung Cancer Patients
- Where
- Beijing, Changsha, Chengdu, Chongqing, Guangzhou, Hangzhou, Hefei, Jinan, Kunming, Linyi, Nanchang, Nanjing, Nanning, Shanghai, Shenyang, Shijiazhuang, Suzhou, Taiyuan, Tianjin, Wuhan, Xiamen, Xi’an, Zhengzhou
- Életkor
- 18 év and over
- People
- 194
- Run by
- Nuvation Bio Inc.
See details and how to joinNCT06564324 - No phaseTaking peopleTo Explore the Safety and Efficacy of Hypervision Proton Surgery for Early-stage Non-small Cell Lung Cancer
- Where
- Hefei
- Életkor
- 18 év and over
- People
- 12
- Run by
- Anhui Provincial Cancer Hospital
See details and how to joinNCT07195084 - 2. fázisNot yet taking people in KínaSacituzumab Tirumotecan in Combination With Anlotinib in Previously Treated Patients With Extensive-Stage Small Cell Lung Cancer (ES-SCLC)
- Where
- Sichuan
- Életkor
- 18 év to 75 év
- People
- 33
- Run by
- Sichuan University
See details and how to joinNCT07501169 - No phaseTaking peopleElectroacupuncture Plus 5-HT3 Receptor Inhibitor for PONV Prevention in High-Risk Patients Undergoing Thoracoscopic Lung Cancer Surgery
- Where
- Shanghai
- Életkor
- 18 év and over
- People
- 204
- Run by
- Shanghai Chest Hospital
See details and how to joinNCT07515027 - 3. fázisTaking peopleIvonescimab in Combination With Docetaxel in Advanced Non-Small Cell Lung Cancer
- Where
- Shanghai
- Életkor
- 18 év to 75 év
- People
- 536
- Run by
- Akeso
See details and how to joinNCT06928389 - 2. fázisTaking peopleA Phase II Clinical Study of FH-006 for Injection Combined With Other Anticancer Therapies in Subjects With Lung Cancer
- Where
- Guangzhou
- Életkor
- 18 év to 75 év
- People
- 200
- Run by
- Jiangsu HengRui Medicine Co., Ltd.
See details and how to joinNCT07241767 - 2. fázisNot yet taking people in KínaCombining Furmonertinib With Local Therapy for Inoperable Early-stage Lung Cancer: A Phase II Trial
- Where
- Shanghai
- Életkor
- 18 év and over
- People
- 45
- Run by
- Shanghai Pulmonary Hospital, Shanghai, China
See details and how to joinNCT07517640 - No phaseCsak meghívásosConcept-verification Clinical Trial on the Inhibition of Breast Cancer Lung Metastasis Progression by Hyperbaric Oxygen
- Where
- Jinan
- Életkor
- 18 év to 75 év
- People
- 10
- Run by
- Jinan Central Hospital
See details and how to joinNCT07514728 - 1/2. fázisTaking peopleA Study of DB-1310 in Advanced/Metastatic Solid Tumors
- Where
- Changchun, Changsha, Chengdu, Nanjing, Shanghai, Shenyang, Wuxi, Zhengzhou
- Életkor
- 18 év and over
- People
- 1000 worldwide
- Run by
- DualityBio Inc.
See details and how to joinNCT05785741 - 3. fázisTaking peopleBevacizumab Plus FSRT Versus Hippocampus-Avoidant WBRT in Lung Adenocarcinoma With Extensive Brain Metastases
- Where
- Chongqing, Guangzhou
- Életkor
- 18 év and over
- People
- 220
- Run by
- Sun Yat-sen University
See details and how to joinNCT07481786 - 2. fázisNot yet taking people in KínaEfficacy and Safety of Sacituzumab Tirumotecan (SKB264) in Combination With Toripalimab in Patients With Initially Unresectable Stage III NSCLC
- Where
- Changsha
- Életkor
- 18 év to 70 év
- People
- 50
- Run by
- Hunan Province Tumor Hospital
See details and how to joinNCT06706219 - No phaseTaking peopleFL-261 Imaging for Cancer Diagnosis and Staging
- Where
- Wuhan
- Életkor
- 18 év and over
- People
- 12
- Run by
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
See details and how to joinNCT07510321 - 2. fázisNot yet taking people in KínaA Phase II Study of Benmelstobart + Anlotinib + Chemotherapy as First-Line Treatment for LCNEC and EP-NEC
- Where
- Tianjin
- Életkor
- 18 év to 75 év
- People
- 48
- Run by
- Tianjin Medical University Cancer Institute and Hospital
See details and how to joinNCT07510594 - 3. fázisTaking peopleImmunonutrition Reduces Acute Esophagitis After Thoracic Radiotherapy in Lung Cancer
- Where
- Changsha, Chenzhou, Hengyang, Yueyang
- Életkor
- 18 év and over
- People
- 121
- Run by
- Hunan Cancer Hospital
See details and how to joinNCT06840704 - No phaseTaking peoplePulsatile High-dose Furmonertinib in EGFR-mutant NSCLC With Leptomeningeal Metastasis
- Where
- Guangzhou
- Életkor
- 18 év to 75 év
- People
- 42
- Run by
- Guangzhou University of Traditional Chinese Medicine
See details and how to joinNCT07348965 - No phaseTaking peopleCadherin 3(CDH3)-Targeted PET in Lung Malignant Tumors
- Where
- Beijing
- Életkor
- 18 év and over
- People
- 80
- Run by
- Peking University People's Hospital
See details and how to joinNCT07487883 - 1/2. fázisTaking peopleNeoadjuvant Therapy With Ensartinib Combined With Chemotherapy for ALK-positive Non - Small Cell Lung Cancer (NSCLC)
- Where
- Xi'an
- Életkor
- 18 év to 75 év
- People
- 20
- Run by
- Tang-Du Hospital
See details and how to joinNCT07354061 - No phaseTaking peopleFAP-targeted PET/NIR in Lung Malignant Tumors
- Where
- Beijing
- Életkor
- 18 év to 70 év
- People
- 200
- Run by
- Peking University People's Hospital
See details and how to joinNCT07498933 - 2. fázisTaking peopleHippocampus-Protective Radiotherapy Combined With Osimertinib for Symptomatic Brain Metastases in EGFR-Mutated Lung Cancer
- Where
- Tianjin
- Életkor
- 18 év to 75 év
- People
- 74
- Run by
- Tianjin Medical University Cancer Institute and Hospital
See details and how to joinNCT07505173 - No phaseTaking peopleLarge Language Models Assist in Tumor MDT
- Where
- Guangzhou
- Életkor
- 25 év to 33 év
- People
- 60
- Run by
- Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
See details and how to joinNCT07504367 - 1. fázisTaking peopleEvaluation of JSKN016 Combination Therapy in Subjects With NSCLC
- Where
- Guangzhou
- Életkor
- 18 év to 75 év
- People
- 288
- Run by
- Jiangsu Alphamab Biopharmaceuticals Co., Ltd
See details and how to joinNCT06868732 - No phaseTaking peopleThoracic Surgery Intercostal Block Trial With Liposomal vs. Hydrochloride Bupivacaine
- Where
- Shanghai
- Életkor
- 18 év to 80 év
- People
- 210
- Run by
- Shanghai Pulmonary Hospital, Shanghai, China
See details and how to joinNCT07134660 - 2. fázisTaking peopleDurvalumab as Consolidation for Patients LS-SCLC
- Where
- Wuhan, Zhengzhou
- Életkor
- 18 év and over
- People
- 100
- Run by
- Qian Chu
See details and how to joinNCT07055581 - No phaseTaking peopleA Retrospective Real-World Study Based on RATIONALE-307
- Where
- Beijing
- People
- 109
- Run by
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
See details and how to joinNCT07478809